FDA eases restrictions around abortion pill, increasing access for rural and low-income women
- The U.S. Food and Drug Administration now allows for mifepristone (Mifeprex) to be legally prescribed and taken further into pregnancy (10 vs. 7 weeks), with reduced dosage (200 vs. 600 mg), and requiring only two rather than three doctor’s visits.
- Medical professionals and researchers have held that the restrictions, based on science from the 1990s, were out of step with advanced medical and pharmacological understanding.
- Conservative states have long restricted access to mifepristone, requiring the drug to be administered by licensed physicians and at times in the presence of the prescribing doctor.
“New F.D.A. Guidelines Ease Access to Abortion Pill” (The New York Times)
“FDA backs expanded use of medical abortion pill” (Reuters)
“FDA Extends Abortion Pill Recommendations To Later In Pregnancy” (BuzzFeed News)
(Image Credit: Gabriella Demczuk/The New York Times)